CME czar goes to Pfizer

Share this article:
Maureen Doyle-Scharff
Maureen Doyle-Scharff
Pfizer, in the midst of revamping its CME department, scored a coup with the recent hiring of Maureen Doyle-Scharff, MBA.

Doyle-Scharff comes from the Ross Products division of Abbott Labs, where for the last two years she directed healthcare education, policy and programs. Her new title at Pfizer is director, medical education, US external medical affairs.

A well-known advocate of CME among all provider groups, Doyle-Scharff holds positions on the boards of several medical education professional groups. Before joining Ross, she was executive director, professional and strategic customer alliances for Johnson & Johnson.

Pfizer's Medical Education Grants department, under the direction of Mike Saxton, MEd, senior director, team leader, is placing more emphasis on the competency of personnel. Earlier this year, the firm made reviewers in the department re-interview for jobs, with candidates required to meet higher standards.

Bringing in someone of high stature, who shares his vision, could put Saxton in a better position to implement his plans, say people familiar with the matter.
Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union